Clinical Trials in Philadelphia

Showing 4961-4980 of 20,904 trials

Actis Total Hip System 2 Year Follow-up

NCT02783274

Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and device and procedure related adverse event assessments.

OsteoarthritisTraumatic ArthritisRheumatoid Arthritis+6 more

DePuy Orthopaedics266 participantsStarted Jul 2016

Louisville, Kentucky, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

NCT02924376

The purpose of this study is evaluate the efficacy of pemigatinib in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocation who have failed at least 1 previous treatment.

Cholangiocarcinoma

Incyte Corporation147 participantsStarted Jan 2017

Anchorage, Alaska, United States • Phoenix, Arizona, United States • Tempe, Arizona, United States +117 more locations

Actis Total Hip System 2 Year Follow-up

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Find Trials by Condition in Philadelphia

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Perceptual-motor Interaction to Improve Bimanual Coordination After Stroke

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

GLP-1R Agonist Treatment for Opioid Use Disorder

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Severe Asthma Research Program

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Topical ENS-002 for Atopic Dermatitis in Adults